Related Experiment Videos
Pre-clinical toxicological studies with muzolimine
Current Medical Research and Opinion
|January 1, 1976
Summary
Muzolimine exhibits low acute toxicity across species. Sub-chronic studies revealed kidney effects primarily due to excessive diuresis, not direct toxicity, with no embryotoxic or teratogenic impacts observed.
Area of Science:
- Pharmacology
- Toxicology
- Animal Studies
Background:
- Muzolimine is a pharmaceutical agent requiring toxicological evaluation.
- Understanding its safety profile is crucial for potential therapeutic applications.
Purpose of the Study:
- To evaluate the acute, sub-chronic, and embryotoxic effects of muzolimine.
- To determine the safety profile of muzolimine in various animal models.
Main Methods:
- Oral administration of muzolimine to mice, rats, rabbits, and dogs.
- Acute toxicity testing.
- 90-day sub-chronic toxicity studies.
- Embryotoxicity studies in pregnant rats and rabbits.
Main Results:
- Muzolimine demonstrated slight acute toxicity, consistent across tested species.
- Sub-chronic studies showed pronounced diuresis in rats and dogs, with kidney changes attributed to pharmacological effects of overdosage (excessive diuresis) rather than direct toxic renal damage.
- Toxic or lethal doses in embryotoxicity studies did not result in embryotoxic or teratogenic effects in rats or rabbits.
Conclusions:
- Muzolimine possesses a favorable safety profile regarding acute toxicity and developmental effects.
- Observed kidney alterations in sub-chronic studies are linked to its diuretic action and not indicative of intrinsic nephrotoxicity.